CERo Therapeutics Holdings, Inc. (CERO)
OTCMKTS · Delayed Price · Currency is USD
0.0106
-0.0052 (-32.91%)
At close: Sep 3, 2026
CERO Market Cap
CERO has a market cap or net worth of $835.13 thousand as of September 4, 2026. Its market cap has decreased by -90.64% in one year.
Market Cap
835.13K
Enterprise Value
17.20M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
ChartMarket Cap Chart
Since November 30, 2021, CERO's market cap has decreased from 222.99M to 835.13K, a decrease of -99.63%. That is a compound annual growth rate of -69.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 759.29K | -46.26% |
| Dec 31, 2025 | 1.41M | -87.73% |
| Dec 31, 2024 | 11.51M | -83.24% |
| Dec 28, 2023 | 68.71M | -70.89% |
| Dec 30, 2022 | 236.01M | 6.05% |
| Dec 31, 2021 | 222.54M | -0.20% |
| Nov 30, 2021 | 222.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Regenerative Medical Technology Group | 1.12M |
| Innovation Pharmaceuticals | 1.06M |
| Evofem Biosciences | 993.98K |
| Neon Bloom | 955.17K |
| ZyVersa Therapeutics | 803.12K |
| Agentix | 801.34K |
| Bio-Path Holdings | 754.46K |
| SQZ Biotechnologies Company | 707.79K |